Basit öğe kaydını göster

dc.contributor.authorERZURUMLU, K
dc.contributor.authorHokelek, MURAT
dc.contributor.authorAMANVERMEZ, R
dc.contributor.authorTAS, K
dc.contributor.authorGONLUSEN, L
dc.date.accessioned2021-03-03T18:16:40Z
dc.date.available2021-03-03T18:16:40Z
dc.date.issued2000
dc.identifier.citationERZURUMLU K., Hokelek M., GONLUSEN L., TAS K., AMANVERMEZ R., "The effect of albendazole on the prevention of secondary hydatidosis", HEPATO-GASTROENTEROLOGY, cilt.47, sa.31, ss.247-250, 2000
dc.identifier.issn0172-6390
dc.identifier.othervv_1032021
dc.identifier.otherav_4e27ae93-a39b-4ec1-86d2-eddd618fb532
dc.identifier.urihttp://hdl.handle.net/20.500.12627/55837
dc.description.abstractBACKGROUND/AIMS: Secondary hydatidosis and recurrence are serious complications in hydatid surgery. Although medical treatment and current surgical techniques are more effective in the prevention of cyst formation resulting from spillage of cystic liquid, secondary hydatidosis is still surgically important. Albendazole, a derivative of benzoimidazole, is the most commonly used drug in the medical treatment of echinococcosis. The effectiveness of pre-operative prolonged or single dose applications is supported by the literature.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleThe effect of albendazole on the prevention of secondary hydatidosis
dc.typeMakale
dc.relation.journalHEPATO-GASTROENTEROLOGY
dc.contributor.departmentOndokuz Mayıs Üniversitesi , ,
dc.identifier.volume47
dc.identifier.issue31
dc.identifier.startpage247
dc.identifier.endpage250
dc.contributor.firstauthorID51775


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster